The Exchange has sought clarification from Sun Pharmaceutical Industries with respect to news article appearing in Business Standard on May 14, 2015 titled ‘Ranbaxy accused of gaming FDA rules to thwart rivals’ which inter-alia states, ‘The lawsuit also names Sun Pharmaceuticals Industries Ltd, which completed its acquisition of Ranbaxy this year’.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.00 |
| Dr. Reddys Lab | 1223.40 |
| Cipla | 1231.75 |
| Zydus Lifesciences | 929.70 |
| Lupin | 2327.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: